Share-based Payment Arrangement, Expense of ANAVEX LIFE SCIENCES CORP. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ANAVEX LIFE SCIENCES CORP. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • ANAVEX LIFE SCIENCES CORP. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,900,000, a 63% increase year-over-year.
  • ANAVEX LIFE SCIENCES CORP. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,500,000, a 22% increase year-over-year.
  • ANAVEX LIFE SCIENCES CORP. annual Share-based Payment Arrangement, Expense for 2025 was $11,500,000, a 22% increase from 2024.
  • ANAVEX LIFE SCIENCES CORP. annual Share-based Payment Arrangement, Expense for 2024 was $9,400,000, a 43% decline from 2023.
  • ANAVEX LIFE SCIENCES CORP. annual Share-based Payment Arrangement, Expense for 2023 was $16,400,000, a 11% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ANAVEX LIFE SCIENCES CORP. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,500,000 $1,900,000 +$3,300,000 +63% 01 Jul 2025 30 Sep 2025 10-K 25 Nov 2025 2025 FY
Q2 2025 $8,200,000 $7,800,000 +$400,000 +5.4% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 $7,800,000 $3,500,000 -$1,400,000 -29% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 $9,200,000 $2,100,000 -$200,000 -8.7% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2025 2025 Q1
Q3 2024 $9,400,000 $5,200,000 -$8,400,000 -262% 01 Jul 2024 30 Sep 2024 10-K 25 Nov 2025 2025 FY
Q2 2024 $17,800,000 $7,400,000 +$3,500,000 +90% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q3
Q1 2024 $14,300,000 $4,900,000 +$900,000 +22% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q2
Q4 2023 $13,400,000 $2,300,000 -$3,000,000 -57% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025 2025 Q1
Q3 2023 $16,400,000 $3,200,000 -$2,863,159 -47% 01 Jul 2023 30 Sep 2023 10-K 25 Nov 2025 2025 FY
Q2 2023 $19,263,159 $3,900,000 -$88,614 -2.2% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q3
Q1 2023 $19,351,773 $4,000,000 -$439,456 -9.9% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q2
Q4 2022 $19,791,229 $5,300,000 +$1,391,229 +36% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024 2024 Q1
Q3 2022 $18,400,000 $6,063,159 +$2,942,554 +94% 01 Jul 2022 30 Sep 2022 10-K 27 Nov 2023 2023 FY
Q2 2022 $15,457,446 $3,988,614 +$1,694,689 +74% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q3
Q1 2022 $13,762,757 $4,439,456 +$2,593,300 +140% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q2
Q4 2021 $11,169,457 $3,908,771 +$2,969,457 +316% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023 2023 Q1
Q3 2021 $8,200,000 $3,120,605 +$2,460,005 +372% 01 Jul 2021 30 Sep 2021 10-K 27 Nov 2023 2023 FY
Q2 2021 $5,739,995 $2,293,925 +$1,042,796 +83% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q3
Q1 2021 $4,697,199 $1,846,156 +$145,403 +8.5% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q2
Q4 2020 $4,551,796 $939,314 -$325,110 -26% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022 2022 Q1
Q3 2020 $4,876,906 $660,600 -$575,930 -47% 01 Jul 2020 30 Sep 2020 10-K 28 Nov 2022 2022 FY
Q2 2020 $5,452,836 $1,251,129 +$16,925 +1.4% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q3
Q1 2020 $5,435,911 $1,700,753 -$192,399 -10% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q2
Q4 2019 $5,628,310 $1,264,424 -$802,563 -39% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q1
Q3 2019 $6,430,873 $1,236,530 -$255,062 -17% 01 Jul 2019 30 Sep 2019 10-K 28 Dec 2020 2020 FY
Q2 2019 $6,685,935 $1,234,204 -$443,527 -26% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q3
Q1 2019 $7,129,462 $1,893,152 +$667,456 +54% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q2
Q4 2018 $6,462,006 $2,066,987 +$945,002 +84% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020 2020 Q1
Q3 2018 $5,517,004 $1,491,592 +$373,898 +33% 01 Jul 2018 30 Sep 2018 10-K 16 Dec 2019 2019 FY
Q2 2018 $5,143,106 $1,677,731 +$518,015 +45% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q3
Q1 2018 $4,625,091 $1,225,696 +$256,803 +27% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q2
Q4 2017 $4,368,288 $1,121,985 +$232,718 +26% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019 2019 Q1
Q3 2017 $4,135,570 $1,117,694 -$3,275,624 -75% 01 Jul 2017 30 Sep 2017 10-K 25 Jan 2019 2018 FY
Q2 2017 $7,411,194 $1,159,716 +$929,477 +404% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q3
Q1 2017 $6,481,717 $968,893 +$746,203 +335% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q2
Q4 2016 $5,735,514 $889,267 +$673,247 +312% 01 Oct 2016 31 Dec 2016 10-Q 07 Feb 2018 2017 Q1
Q3 2016 $5,062,267 $4,393,318 01 Jul 2016 30 Sep 2016 10-K 25 Jan 2019 2018 FY
Q2 2016 $230,239 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q3
Q1 2016 $222,690 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q2
Q4 2015 $216,020 01 Oct 2015 31 Dec 2015 10-Q 07 Feb 2017 2017 Q1

ANAVEX LIFE SCIENCES CORP. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $11,500,000 +$2,100,000 +22% 01 Oct 2024 30 Sep 2025 10-K 25 Nov 2025 2025 FY
2024 $9,400,000 -$7,000,000 -43% 01 Oct 2023 30 Sep 2024 10-K 25 Nov 2025 2025 FY
2023 $16,400,000 -$2,000,000 -11% 01 Oct 2022 30 Sep 2023 10-K 25 Nov 2025 2025 FY
2022 $18,400,000 +$10,200,000 +124% 01 Oct 2021 30 Sep 2022 10-K 27 Nov 2023 2023 FY
2021 $8,200,000 +$3,323,094 +68% 01 Oct 2020 30 Sep 2021 10-K 27 Nov 2023 2023 FY
2020 $4,876,906 -$1,553,967 -24% 01 Oct 2019 30 Sep 2020 10-K 28 Nov 2022 2022 FY
2019 $6,430,873 +$913,869 +17% 01 Oct 2018 30 Sep 2019 10-K 28 Dec 2020 2020 FY
2018 $5,517,004 +$1,381,434 +33% 01 Oct 2017 30 Sep 2018 10-K 16 Dec 2019 2019 FY
2017 $4,135,570 -$926,697 -18% 01 Oct 2016 30 Sep 2017 10-K 25 Jan 2019 2018 FY
2016 $5,062,267 +$3,428,288 +210% 01 Oct 2015 30 Sep 2016 10-K 25 Jan 2019 2018 FY
2015 $1,633,979 +$1,606,054 +5751% 01 Oct 2014 30 Sep 2015 10-K 11 Dec 2017 2017 FY
2014 $27,925 01 Oct 2013 30 Sep 2014 10-K 14 Dec 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.